WeTrials
Completed

Trial of Topical Cysteamine in the Treatment of Corneal Cystine Crystal Accumulation in Cystinosis

What is this study?

This study tests whether special eye drops containing cysteamine can safely and effectively clear painful cystine crystals from the surface of the eyes in people with cystinosis. While oral medications help other parts of the body, these eye drops specifically target the eye crystals that can cause irritation and vision issues over time.

Who can participate?

You may be able to join if you are at least two years old and have a confirmed diagnosis of cystinosis. Participants also need to be able to travel to the study location and cooperate with specialized eye examinations.

What will happen?

Participants use cysteamine eye drops regularly as directed and visit the clinic for check-ups, which include specialized eye exams to measure the crystals. The study carefully monitors the long-term safety and effectiveness of these eye drops.

Where and when?

This study takes place at the National Institutes of Health in Bethesda, Maryland, and the study has now been completed.

Key Points
  • 1Testing cysteamine eye drops to remove painful crystals from the eyes
  • 2Open to patients with cystinosis who are at least 2 years old
  • 3Involves regular eye exams and consistent use of the prescribed eye drops

No related links yet

Seen this study covered in the news, or found a page that explains it well? Send it over and we'll review it.

Suggest a link
Conditions Studied
This study is investigating treatments for the following conditions
Cystinosis

This summary was generated using AI and may not capture all details. Always consult with a healthcare professional for medical advice.